Ceritinib
| CAS No. | 1032900-25-6 |
|---|---|
| MDL No. | MFCD26142648 |
| MF | C28H36ClN5O3S |
| MW | 558.10 |
| InChI Key | VERWOWGGCGHDQE-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Ceritinib is an aminopyrimidine with the structure of 2,6-diamino-5-chloropyrimidine, where the amino groups at positions 2 and 6 are substituted with 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonyl)phenyl, respectively. It is used in the treatment of ALK-positive metastatic non-small cell lung cancer. Ceritinib functions as an antineoplastic agent and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is also classified as an aromatic ether, organochlorine compound, secondary amino compound, piperidine, and sulfone.
| CAS No. | 1032900-25-6 |
|---|---|
| Product Name | Ceritinib |
Biological Targets
ALK·EML4·NPM1
Associated Conditions
melanoma·non-small cell lung carcinoma·anaplastic large cell lymphoma·cancer·liver disease·
* The information provided here is compiled from public sources and is for reference only.
